Russell Investments Group’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-44,576
Closed -$28.3K 3864
2025
Q1
$28.3K Buy
44,576
+10,522
+31% +$6.69K ﹤0.01% 3035
2024
Q4
$35.1K Sell
34,054
-13,595
-29% -$14K ﹤0.01% 2899
2024
Q3
$56.2K Buy
47,649
+4,835
+11% +$5.71K ﹤0.01% 2766
2024
Q2
$52.2K Buy
42,814
+16
+0% +$20 ﹤0.01% 2755
2024
Q1
$93.3K Buy
42,798
+1,073
+3% +$2.34K ﹤0.01% 2584
2023
Q4
$64.7K Sell
41,725
-3,901
-9% -$6.05K ﹤0.01% 2611
2023
Q3
$58.9K Sell
45,626
-8,079
-15% -$10.4K ﹤0.01% 2727
2023
Q2
$92.4K Sell
53,705
-3,350
-6% -$5.76K ﹤0.01% 2619
2023
Q1
$86.2K Sell
57,055
-1,192
-2% -$1.8K ﹤0.01% 2616
2022
Q4
$93.2K Sell
58,247
-3,073
-5% -$4.92K ﹤0.01% 2682
2022
Q3
$88K Sell
61,320
-174,150
-74% -$250K ﹤0.01% 2688
2022
Q2
$429K Buy
235,470
+150,091
+176% +$273K ﹤0.01% 2318
2022
Q1
$227K Sell
85,379
-45,672
-35% -$121K ﹤0.01% 2434
2021
Q4
$567K Sell
131,051
-35,359
-21% -$153K ﹤0.01% 2398
2021
Q3
$846K Sell
166,410
-2,053
-1% -$10.4K ﹤0.01% 2261
2021
Q2
$1.07M Sell
168,463
-16,045
-9% -$101K ﹤0.01% 2281
2021
Q1
$1.42M Sell
184,508
-43,734
-19% -$336K ﹤0.01% 2081
2020
Q4
$1.5M Sell
228,242
-259,428
-53% -$1.7M ﹤0.01% 1910
2020
Q3
$3.24M Buy
487,670
+384,490
+373% +$2.56M 0.01% 1394
2020
Q2
$857K Buy
103,180
+9,202
+10% +$76.4K ﹤0.01% 2140
2020
Q1
$718K Buy
93,978
+50,084
+114% +$383K ﹤0.01% 2006
2019
Q4
$363K Buy
+43,894
New +$363K ﹤0.01% 2512
2018
Q4
Sell
-25,248
Closed -$467K 2935
2018
Q3
$467K Sell
25,248
-101,571
-80% -$1.88M ﹤0.01% 2418
2018
Q2
$2.9M Sell
126,819
-64,382
-34% -$1.47M 0.01% 1559
2018
Q1
$5.44M Buy
191,201
+83,448
+77% +$2.37M 0.01% 1324
2017
Q4
$2.38M Buy
107,753
+92,305
+598% +$2.04M ﹤0.01% 1735
2017
Q3
$281K Sell
15,448
-6,686
-30% -$122K ﹤0.01% 2603
2017
Q2
$343K Buy
22,134
+292
+1% +$4.53K ﹤0.01% 2548
2017
Q1
$377K Hold
21,842
﹤0.01% 2530
2016
Q4
$243K Buy
+21,842
New +$243K ﹤0.01% 2669